Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening

Diagnostics - Switzerland
doi 10.3390/diagnostics9020056
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Molecular Mechanisms of Drug Resistance in Mycobacterium Tuberculosis

Annual Review of Biochemistry
Biochemistry
1996English

Economic Feasibility of New Chemotherapy Regimens for Treatment of Tuberculosis Patients With Extensive Drug Resistance

Tuberkulëz i bolezni lëgkikh
PulmonaryInfectious DiseasesRespiratory Medicine
2018English

Systematic Review of the Performance of Rapid Rifampicin Resistance Testing for Drug-Resistant Tuberculosis

PLoS ONE
Multidisciplinary
2013English

A Study of Drug Resistance TB Among Patients With New Sputum Smear Positive Pulmonary Tuberculosis

IOSR Journal of Dental and Medical Sciences
2016English

Direct Drug Susceptibility Testing of Mycobacterium Tuberculosis for Rapid Detection of Multidrug Resistance Using the Bactec MGIT 960 System: A Multicenter Study

Journal of Clinical Microbiology
Microbiology
2011English

Drug Resistance of Mycobacterium Tuberculosis

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2010English

Determining Mycobacterium Tuberculosis Drug Resistance and Risk Factors for Multidrug-Resistant Tuberculosis in Sputum Smear-Positive Tuberculosis Outpatients in Anhui Province, China, 2015–2016

Infection and Drug Resistance
Infectious DiseasesPharmacology
2020English

A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Molecular Testing and the Pathologist's Role in Clinical Trials of Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy